Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NSRX

Nasus Pharma Ltd

CIK 0002029039 · NYSE American

NYSE AmericanHealth CarePharmaceutical Preparations
$4.00
↑ 0.15 (3.90%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$46.84M
P/E Ratio
-8.00
EPS
-0.72
Dividend Yield
Not covered
52W Position
25%
Beta
0.79

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
16.92
P/S
0.04
EV/Revenue
0.04
ROE
-211.6%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 25%
$1.98$9.99

Latest Financials

2025-12-31 FY
Revenue
$1.24B
Net Income
-$5.86M
Total Assets
$5.00M
Free Cash Flow
-$4.93M

Recent news